BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22595938)

  • 1. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome.
    Mester J; Eng C
    Genet Med; 2012 Sep; 14(9):819-22. PubMed ID: 22595938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
    Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
    Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N
    Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular aspects of PTEN mutations in 10 pediatric patients.
    Isik E; Simsir OS; Solmaz AE; Onay H; Atik T; Aykut A; Durmaz A; Cogulu O; Ozkinay F
    Ann Hum Genet; 2020 Jul; 84(4):324-330. PubMed ID: 32162695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
    Mester JL; Moore RA; Eng C
    Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
    Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
    Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN hamartoma tumor syndrome.
    Mester J; Charis E
    Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.
    Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C
    Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PTEN germline mutation in a family with mild phenotype: difficulties in genetic counseling.
    Busa T; Chabrol B; Perret O; Longy M; Philip N
    Gene; 2013 Jan; 512(2):194-7. PubMed ID: 23124040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations.
    Vanderver A; Tonduti D; Kahn I; Schmidt J; Medne L; Vento J; Chapman KA; Lanpher B; Pearl P; Gropman A; Lourenco C; Bamforth JS; Sharpe C; Pineda M; Schallner J; Bodamer O; Orcesi S; Oberstein SA; Sistermans EA; Yntema HG; Bonnemann C; Waldman AT; van der Knaap MS
    Am J Med Genet A; 2014 Mar; 164A(3):627-33. PubMed ID: 24375884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of PTEN mosaicism: the relevance of additional tumor DNA sequencing. A case report and review of the literature.
    Cavaillé M; Crampon D; Achim V; Bubien V; Uhrhammer N; Privat M; Ponelle-Chachuat F; Gay-Bellile M; Lepage M; Ouedraogo ZG; Jones N; Bidet Y; Sevenet N; Bignon YJ
    BMC Med Genomics; 2023 Jul; 16(1):166. PubMed ID: 37442961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
    Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
    Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
    Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
    Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.
    Kurek KC; Howard E; Tennant LB; Upton J; Alomari AI; Burrows PE; Chalache K; Harris DJ; Trenor CC; Eng C; Fishman SJ; Mulliken JB; Perez-Atayde AR; Kozakewich HP
    Am J Surg Pathol; 2012 May; 36(5):671-87. PubMed ID: 22446940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
    Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
    JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.
    Tan MH; Mester J; Peterson C; Yang Y; Chen JL; Rybicki LA; Milas K; Pederson H; Remzi B; Orloff MS; Eng C
    Am J Hum Genet; 2011 Jan; 88(1):42-56. PubMed ID: 21194675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN mosaicism with features of Cowden syndrome.
    Gammon A; Jasperson K; Pilarski R; Prior T; Kuwada S
    Clin Genet; 2013 Dec; 84(6):593-5. PubMed ID: 23240978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
    Orloff MS; Eng C
    Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.